First trial tests Genetic-Guided 'Chemo Cocktail' for tough cancers
NCT ID NCT04361708
Summary
This early-stage study aims to find the safest dose of a powerful combination of five chemotherapy drugs for people with advanced cancers of the stomach, pancreas, and related areas. It uses a patient's genetic test results to personalize the dose of one key drug, hoping to reduce side effects. The goal is to control the cancer's growth and gather information to design future studies with curative intent.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Chicago
RECRUITINGChicago, Illinois, 60637, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.